SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJpel Priv Eqty Regulatory News (JPEL)

Share Price Information for Jpel Priv Eqty (JPEL)

Share Price is delayed by 15 minutes
Get Live Data
1.24    0.00 (0.00%)
Bid:
1.20
Ask:
1.28
Spread: 0.08 (6.667%)
Market Cap: $21.21m
JPEL Live PriceLast checked at - London Stock Exchange

Intraday Jpel Priv Eqty Share Chart

Final Close

29 Sep 2009 09:25

RNS Number : 8355Z
J.P. Morgan Private Equity Ltd
29 September 2009
 



J.P. Morgan Private Equity Limited Announces Final Close on $93.4 mm following an Oversubscribed Offering of US$ Equity Shares 

* * *

GUERNSEY29 SEPTEMBER 2009 

J.P. Morgan Private Equity Limited ("JPEL" or the "Company"), London Stock Exchange listed private equity secondary fund, has held a final closing of its 2009 discounted offering of US$ Equity Shares. The 2009 offering raised over US$93.4 million in total, almost twice the amount of its initial fundraising target of US$50 million. The offering's final close, held on 24 September 2009was oversubscribed.

"We were delighted to hold an oversubscribed final close for JPEL US$ Equity Shares in such a challenging fundraising environment," said JPEL Chairman Trevor Ash.

The 24 September 2009 close represented the last offering of US$ Equity Shares at a discount to NAV, pursuant to the authority granted at an extraordinary general meeting of shareholders  on 16 July 2009. JPEL currently has no intention of publishing a prospectus in order to issue further US$ Equity Shares at a discount to net asset value pursuant to that shareholder authority.

"We believe that the Company's ability to exceed the initial fundraising target is a great indicator of JPEL's capabilities in challenging markets and continues to validate the Company's value-oriented secondary private equity investment approach,commented Greg Getschow, JPEL's co-lead portfolio manager.

"We believe that the current market for secondary private equity investments represents a significant opportunity for JPEL to deploy capital in accretive transactions," added Troy Duncan, JPEL's co-lead portfolio manager. 

JPEL's primary strategy is to acquire secondary market portfolios of direct fund investments, significantly invested partnership interests and partially drawn commitments, in order to target accelerated NAV development. JPEL employs an opportunistic, deep value private equity investment strategy and focuses on value-oriented investments with potential for early return of capital. 

* * *

About J.P. Morgan Private Equity Limited 

J.P. Morgan Private Equity Limited is a Guernsey registered and incorporated, London Stock Exchange-listed, closed-ended investment company (LSE: JPEL, JPEZ, JPZZ) designed primarily to invest in the global private equity market. The investment objective of the Company is to achieve both short and long-term capital appreciation by investing in a well diversified portfolio of private equity fund interests and by capitalising on the inefficiencies of the secondary private equity market.  The Company's capital structure consists of three classes of shares: Equity Shares and two classes of Zero Dividend Preference Shares due 2013 and 2015, respectively.

On 17 August 2009, JPEL issued warrants free of subscription cost to shareholders on record. The warrants are publicly traded on the London Stock Exchange under the symbol "JPWW." 

J.P. Morgan Private Equity Limited

Troy Duncan / Gregory Getschow

Telephone: +44 (0) 20 7742 3032 / +1 212 648 1150

Peregrine Communications

Anthony Payne / Paul Mungo

Telephone: +44 (0) 20 3178 6869 / +44 (0)20 7822 2307

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCPUUCPBUPBURB
Date   Source Headline
28th Sep 20181:10 pmRNSAnnual Financial Report - 30 June 2018
17th Sep 20187:00 amRNSNet Asset Value(s) - June 2018
22nd Aug 20185:11 pmRNSHolding(s) in Company
20th Jul 20187:00 amRNSNet Asset Value(s) - May 2018
3rd Jul 20187:00 amRNSNet Asset Value(s) - April 2018
9th May 20187:00 amRNSNet Asset Value(s) - March 2018
13th Apr 20189:30 amRNSNet Asset Value(s) - February 2018
11th Apr 20187:00 amRNSNotice to Shareholders - Total Voting Rights
10th Apr 20182:24 pmRNSCompletion of Fourth Mandatory Redemption
22nd Mar 20187:00 amRNSHalf-year Report - 31 December 2017
22nd Mar 20187:00 amRNSMandatory Redemption- US$Equity Shares -April 2018
12th Mar 20187:00 amRNSNet Asset Value(s) - January 2018
2nd Feb 20187:00 amRNSNet Asset Value(s) - December 2017
15th Jan 20187:00 amRNSNet Asset Value(s) - November 2017
29th Dec 20171:15 pmRNSNotice to Shareholders - Key Information Document
14th Dec 20175:50 pmRNSNotice to Shareholders - Total Voting Rights
14th Dec 20177:00 amRNSCompletion Of Third Mandatory Redemption
4th Dec 20172:52 pmRNSAGM Results
4th Dec 20179:44 amRNSNet Asset Value(s) - October 2017 Review
1st Dec 20177:05 amRNSMandatory Redemption - US$Equity Shares - Dec 2017
1st Dec 20177:00 amRNSNet Asset Value(s) - October 2017
24th Nov 20177:00 amRNSSale of Celerion
20th Nov 20172:59 pmRNSHolding(s) in Company
15th Nov 201710:11 amRNSRetirement of 2017 ZDP Shares
9th Nov 20177:00 amRNS2017 AGM CIRCULAR
27th Oct 20174:33 pmRNSHolding(s) in Company
27th Oct 20177:00 amRNSNet Asset Value(s) - September 2017
17th Oct 20179:40 amRNSDirector Declaration
13th Oct 20177:00 amRNSTiming of Retirement of 2017 ZDP Shares
11th Oct 20177:00 amRNSBerkshire Partners Acquires Accela
28th Sep 20177:00 amRNSAnnual Financial Report
27th Sep 20179:45 amRNSDirector Update
26th Sep 201711:11 amRNSNet Asset Value(s) - August 2017
7th Sep 20177:00 amRNSNet Asset Value(s) - July 2017
21st Aug 20172:21 pmRNSHolding(s) in Company
3rd Aug 20177:00 amRNSNet Asset Value(s) - June 2017
5th Jul 20175:50 pmRNSNet Asset Value(s) - May 2017 Correction
30th Jun 20179:52 amRNSNet Asset Value(s) - May 2017
2nd Jun 20177:00 amRNSNet Asset Value(s) - April 2017
30th May 20174:34 pmRNSHolding(s) in Company
25th May 20174:42 pmRNSHolding(s) in Company
2nd May 20173:50 pmRNSNotice to Shareholders - Total Voting Rights
2nd May 20177:00 amRNSCompletion of Mandatory Redemption_ April 2017
24th Apr 20176:15 pmRNSNotification of Dealings in Shares
21st Apr 20177:00 amRNSQuarter End Review for March 2017
12th Apr 20177:00 amRNSMandatory Redemption_US$ Equity Shares_April 2017
11th Apr 20175:22 pmRNSNet Asset Value(s) - March 2017
7th Apr 20177:00 amRNSNet Asset Value(s) - February 2017
28th Mar 20174:56 pmRNSHalf-year Report
16th Mar 20176:04 pmRNSSale of Datamars

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.